Integra LifeSciences Holdings Corporation IART
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.85M | 4.48M | -4.62M | -1.70M | -5.40M |
| Total Depreciation and Amortization | 39.06M | 38.14M | 38.43M | 38.43M | 38.52M |
| Total Amortization of Deferred Charges | 1.07M | 1.02M | 995.00K | 1.02M | 1.32M |
| Total Other Non-Cash Items | 3.81M | 5.29M | 5.62M | -10.58M | -17.83M |
| Change in Net Operating Assets | 37.19M | -26.13M | -30.62M | -15.35M | 24.30M |
| Cash from Operations | 95.98M | 22.80M | 9.80M | 11.82M | 40.91M |
| Capital Expenditure | -10.25M | -12.31M | -14.85M | -17.21M | -15.16M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -30.98M | -- | -17.69M | -432.00K |
| Cash from Investing | -10.25M | -43.28M | -14.85M | -34.91M | -15.59M |
| Total Debt Issued | 19.90M | 31.40M | 44.50M | 49.70M | 603.70M |
| Total Debt Repaid | -65.99M | -24.89M | -35.59M | -25.09M | -613.67M |
| Issuance of Common Stock | 0.00 | 0.00 | 760.00K | 0.00 | 0.00 |
| Repurchase of Common Stock | -200.00K | -214.00K | -1.38M | -137.00K | -199.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -7.12M | -- | -134.00K | -75.00K |
| Cash from Financing | -46.29M | -818.00K | 8.30M | 24.34M | -10.25M |
| Foreign Exchange rate Adjustments | -1.60M | -1.10M | -1.49M | 1.61M | -801.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.85M | -22.39M | 1.76M | 2.86M | 14.27M |